Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 56

1.

Remission of positive symptoms according to the "remission in Schizophrenia Working Group" criteria: a longitudinal study of cognitive functioning.

Braw Y, Sitman R, Cohen M, Berger U, Lev-Ran S, Segev A, Bloch Y, Levkovitz Y.

Eur Psychiatry. 2013 Jun;28(5):282-7. doi: 10.1016/j.eurpsy.2012.04.003. Epub 2012 Sep 16.

PMID:
22989950
2.

Symptomatic remission and neurocognitive functioning in patients with schizophrenia.

Hofer A, Bodner T, Kaufmann A, Kemmler G, Mattarei U, Pfaffenberger NM, Rettenbacher MA, Trebo E, Yalcin N, Fleischhacker WW.

Psychol Med. 2011 Oct;41(10):2131-9. doi: 10.1017/S0033291711000353. Epub 2011 Mar 22.

PMID:
21426601
3.

Executive functioning during full and partial remission (positive and negative symptomatic remission) of schizophrenia.

Braw Y, Benozio A, Levkovitz Y.

Schizophr Res. 2012 Dec;142(1-3):122-8. doi: 10.1016/j.schres.2012.10.011. Epub 2012 Nov 3.

PMID:
23127380
4.

One-year functional outcomes of naturalistically treated patients with schizophrenia.

Spellmann I, Riedel M, Schennach R, Seemüller F, Obermeier M, Musil R, Jäger M, Schmauß M, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkötter J, Heuser I, Maier W, Lemke MR, Rüther E, Klingberg S, Gastpar M, Möller HJ.

Psychiatry Res. 2012 Aug 15;198(3):378-85. doi: 10.1016/j.psychres.2011.12.047. Epub 2012 Mar 14.

PMID:
22421065
5.

Premorbid functioning, cognitive functioning, symptoms and outcome in schizophrenia.

Addington J, Addington D.

J Psychiatry Neurosci. 1993 Jan;18(1):18-23.

6.

[Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].

Bralet MC, Navarre M, Eskenazi AM, Lucas-Ross M, Falissard B.

Encephale. 2008 Dec;34(6):557-62. doi: 10.1016/j.encep.2007.12.005. Epub 2008 Jul 9. French.

PMID:
19081451
7.

Psychopathology, cognitive function, and social functioning of patients with schizophrenia.

Santosh S, Dutta Roy D, Kundu PS.

East Asian Arch Psychiatry. 2013 Jun;23(2):65-70.

8.

Remission criteria and functional outcome in patients with schizophrenia, a longitudinal study.

Heering HD, Janssens M, Boyette LL, van Haren NE; G.R.O.U.P investigators.

Aust N Z J Psychiatry. 2015 Mar;49(3):266-74. doi: 10.1177/0004867414557680. Epub 2014 Nov 18.

PMID:
25406458
9.

Predictors of longitudinal changes in schizophrenia: the role of processing speed.

Sánchez P, Ojeda N, Peña J, Elizagárate E, Yoller AB, Gutiérrez M, Ezcurra J.

J Clin Psychiatry. 2009 Jun;70(6):888-96. doi: 10.4088/JCP.08m04294. Epub 2009 May 5.

PMID:
19422757
10.

Course of cognitive functioning during the stabilization phase of schizophrenia.

Klingberg S, Wittorf A, Sickinger S, Buchkremer G, Wiedemann G.

J Psychiatr Res. 2008 Mar;42(4):259-67. Epub 2007 Apr 2.

PMID:
17400252
11.

Neurocognitive functioning as intermediary phenotype and predictor of psychosocial functioning across the psychosis continuum: studies in schizophrenia and bipolar disorder.

Jabben N, Arts B, van Os J, Krabbendam L.

J Clin Psychiatry. 2010 Jun;71(6):764-74. doi: 10.4088/JCP.08m04837yel. Epub 2010 Jan 26.

PMID:
20122370
12.

Cognitive disorders in the positive, negative, and disorganization syndromes of schizophrenia.

Cuesta MJ, Peralta V.

Psychiatry Res. 1995 Oct 16;58(3):227-35.

PMID:
8570778
13.

Stability of performance on neuropsychological tests in patients with schizophrenia.

Rosmark B, Osby U, Engelbrektson K, Nyman H.

Eur Arch Psychiatry Clin Neurosci. 1999;249(6):299-304.

PMID:
10653286
14.

Remission in schizophrenia: a community-based 6-year follow-up study in Bali.

Kurihara T, Kato M, Reverger R, Tirta IG.

Psychiatry Clin Neurosci. 2011 Aug;65(5):476-82. doi: 10.1111/j.1440-1819.2011.02246.x.

15.

Stability and course of neuropsychological deficits in schizophrenia.

Heaton RK, Gladsjo JA, Palmer BW, Kuck J, Marcotte TD, Jeste DV.

Arch Gen Psychiatry. 2001 Jan;58(1):24-32.

PMID:
11146755
16.

Cognitive enhancement therapy for schizophrenia: effects of a 2-year randomized trial on cognition and behavior.

Hogarty GE, Flesher S, Ulrich R, Carter M, Greenwald D, Pogue-Geile M, Kechavan M, Cooley S, DiBarry AL, Garrett A, Parepally H, Zoretich R.

Arch Gen Psychiatry. 2004 Sep;61(9):866-76.

PMID:
15351765
17.

Remitted but still impaired? Symptomatic versus functional remission in patients with schizophrenia.

Karow A, Moritz S, Lambert M, Schöttle D, Naber D; EGOFORS Initiative.

Eur Psychiatry. 2012 Aug;27(6):401-5. doi: 10.1016/j.eurpsy.2011.01.012. Epub 2011 May 12.

PMID:
21570262
18.

Investigating the neuropsychological and neuroanatomical changes that occur over the first 2-3 years of illness in patients with first-episode schizophrenia.

Zipparo L, Whitford TJ, Redoblado Hodge MA, Lucas S, Farrow TF, Brennan J, Gomes L, Williams LM, Harris AW.

Prog Neuropsychopharmacol Biol Psychiatry. 2008 Feb 15;32(2):531-8. Epub 2007 Oct 25.

PMID:
18061326
19.

Cognitive impairment in elderly patients with schizophrenia: age related changes.

Harvey PD.

Int J Geriatr Psychiatry. 2001 Dec;16 Suppl 1:S78-85. Review.

PMID:
11748791
20.

Supplemental Content

Support Center